Volunteer Screening for Vaccine and Antivirals Clinical Trials
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01593709 |
Recruitment Status
:
Recruiting
First Posted
: May 8, 2012
Last Update Posted
: April 4, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background:
- Vaccines and antiviral therapies are critical for preventing and treating viral diseases. Testing these vaccines and drugs often requires healthy volunteers. To ensure that volunteers are healthy and eligible to participate in these studies, they will be screened before the start of the study. This screening may involve a medical history, physical exam, and blood test. Other samples may also be collected. This study will help identify volunteers who are eligible to participate in vaccine or antiviral therapy trials.
Objectives:
- To screen volunteers for clinical trials of vaccines or drugs to treat or prevent virus infections.
Eligibility:
- Healthy volunteers at least 18 years of age.
Design:
- Screening may begin several months before the start of the clinical trial. Participants may come to the National Institutes of Health clinic one or more times.
- Participants may be screened with a physical exam and medical history. Blood samples will be collected. Other samples may also be collected, including urine, nasal wash, nasal swab, or stool samples. All samples will be stored for reference by the study researchers.
Condition or disease |
---|
Healthy Volunteer |
Study Type : | Observational |
Estimated Enrollment : | 1000 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Screening of Volunteers for Clinical Trials of Investigational and Licensed Vaccines, Antiviral Products, or Live Virus Challenge Studies |
Study Start Date : | May 15, 2012 |
- To screen subjects for their eligibility to participate in clinical trials of investigational or licensed vaccines, antiviral products, or live virus challenge studies being evaluated for research purposes. [ Time Frame: Every patient contact ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 99 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
-
INCLUSION CRITERIA:
- Age: 18 years of age or older
- Available to participate for the planned duration of the clinical trial for which the screening is being done
- Able and willing to complete the informed consent process
- Agree to have blood and/or urine, stool, nasal wash samples, or cervicovaginal secretion samples collected and stored for future studies of investigational or licensed products, the immune system, and/or infectious diseases
- Agree to participate in procedures, such as electrocardiogram or pulmonary function tests, as needed for the clinical trial screening process.
EXCLUSION CRITERIA:
- A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
- Known to be pregnant or breast-feeding
- Receipt of immunoglobulin within the past 6 months or anticipated within the next year
- Any other condition that in the opinion of the investigator would make the subject unsuitable for enrollment or could interfere with the subject participating in and completing the study
- Use of illicit drugs or alcohol dependency or abuse

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01593709
Contact: Krista S Gangler, R.N. | (301) 761-6437 | krista.gangler@nih.gov | |
Contact: Jeffrey I Cohen, M.D. | jcohen@niaid.nih.gov |
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
Bethesda, Maryland, United States, 20892 | |
Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov |
Principal Investigator: | Jeffrey I Cohen, M.D. | National Institute of Allergy and Infectious Diseases (NIAID) |
Additional Information:
Responsible Party: | National Institute of Allergy and Infectious Diseases (NIAID) |
ClinicalTrials.gov Identifier: | NCT01593709 History of Changes |
Other Study ID Numbers: |
120121 12-I-0121 |
First Posted: | May 8, 2012 Key Record Dates |
Last Update Posted: | April 4, 2018 |
Last Verified: | March 27, 2018 |
Keywords provided by National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) ):
Healthy Volunteers |
Additional relevant MeSH terms:
Antiviral Agents Anti-Infective Agents |